Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome ? RECONNECT
| Status | Active |
|---|---|
| Effective start/end date | 9/21/21 → 9/30/26 |
Funding
- ZYNERBA PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.